2020
DOI: 10.1016/j.radmp.2020.08.003
|View full text |Cite
|
Sign up to set email alerts
|

General principles of developing novel radioprotective agents for nuclear emergency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 86 publications
0
4
0
Order By: Relevance
“…Based on the aforementioned mechanism, radiationprotective agents, such as the thiolated compound amifostine and superoxide dismutase (SOD), are commonly employed to inhibit X-ray-induced oxidative stress reactions in clinical practice. 15 However, there are limitations associated with these agents. Amifostine can only be administered intravenously and cannot directly target the skin.…”
Section: Introductionmentioning
confidence: 99%
“…Based on the aforementioned mechanism, radiationprotective agents, such as the thiolated compound amifostine and superoxide dismutase (SOD), are commonly employed to inhibit X-ray-induced oxidative stress reactions in clinical practice. 15 However, there are limitations associated with these agents. Amifostine can only be administered intravenously and cannot directly target the skin.…”
Section: Introductionmentioning
confidence: 99%
“…The search for novel antioxidant and radioprotective substances for medical purposes is a task of high importance, despite the progress that has already been made. Radioprotectors are highly desired agents for radiation therapy [ 6 , 7 , 8 , 9 ]. Antioxidants may find their use in future therapies for aging and aging-related conditions, such as inflammaging, one of the crucial hallmarks of aging [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…In order to reach this goal, radioprotectors are used—compounds that shield the organism from damage to its molecules, cells, organs, and tissues mainly by inactivating ROS and other damaging agents [ 5 ]. Despite significant progress in the development of radioprotective substances for military use, there is still a need for new selective radioprotectors and radiomitigators for medical applications, in particular for radiation therapy [ 6 , 7 , 8 , 9 , 10 ]. By using new functional nanomaterials and various approaches, including molecular systems, it is possible to enhance the damaging effect of ionizing radiation on tumor cells by changing their radiosensitivity [ 11 ].…”
Section: Introductionmentioning
confidence: 99%